Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

56 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 2015 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class I · High risk

Ultra Zx Dietary Supplement

Marketed Without An Approved NDA/ANDA: FDA laboratory analysis confirmed that ULTRA ZX contains undeclared sibutramine and phenolphthalein

Terminated Chemical / undeclared Ultra ZX Supplements D-0991-2015
Class I · High risk

iNSANE Bee Pollen capsules

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared phenolphthalein and fluoxetine, making iNSANE an unapproved drug.

Terminated Chemical / undeclared Detox Transforms D-0981-2015
Class I · High risk

BtRiM Max capsules

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared phenolphthalein, making BtRiM Max an unapproved drug.

Terminated Chemical / undeclared Detox Transforms D-0980-2015
Class I · High risk

AMPD GOLD Bee Pollen capsules

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, making AMPD GOLD an unapproved drug.

Terminated Chemical / undeclared Detox Transforms D-0979-2015
Class I · High risk

iNDiGO capsules

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared phenolphthalein, making iNDiGO an unapproved drug.

Terminated Chemical / undeclared Detox Transforms D-0978-2015

Recalls by year